[1]
“Molecular docking and cytotoxicity interactions of naringenin and its nano-structured lipid carriers in ERα positive breast cancer”, IJBB, vol. 60, no. 2, pp. 141–147, Jun. 2023, doi: 10.56042/ijbb.v60i2.70688.